4.6 Article

Quantile-Optimal Treatment Regimes

期刊

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
卷 113, 期 523, 页码 1243-1254

出版社

AMER STATISTICAL ASSOC
DOI: 10.1080/01621459.2017.1330204

关键词

Dynamic treatment regime; Nonstandard asymptotics; Optimal treatment regime; Precision medicine; Quantile criterion

资金

  1. NSF [DMS1512267, DMS-1712706, DMS-1555244]
  2. NCI [P01 CA142538]
  3. NATIONAL CANCER INSTITUTE [P01CA142538] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Finding the optimal treatment regime (or a series of sequential treatment regimes) based on individual characteristics has important applications in areas such as precision medicine, government policies, and active labor market interventions. In the current literature, the optimal treatment regime is usually defined as the one that maximizes the average benefit in the potential population. This article studies a general framework for estimating the quantile-optimal treatment regime, which is of importance in many real-world applications. Given a collection of treatment regimes, we consider robust estimation of the quantile-optimal treatment regime, which does not require the analyst to specify an outcome regression model. We propose an alternative formulation of the estimator as a solution of an optimization problem with an estimated nuisance parameter. This novel representation allows us to investigate the asymptotic theory of the estimated optimal treatment regime using empirical process techniques. We derive theory involving a nonstandard convergence rate and a nonnormal limiting distribution. The same nonstandard convergence rate would also occur if the mean optimality criterion is applied, but this has not been studied. Thus, our results fill an important theoretical gap for a general class of policy search methods in the literature. The article investigates both static and dynamic treatment regimes. In addition, doubly robust estimation and alternative optimality criterion such as that based on Gini's mean difference or weighted quantiles are investigated. Numerical simulations demonstrate the performance of the proposed estimator. A data example from a trial in HIV+ patients is used to illustrate the application. Supplementary materials for this article are available online.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据